Kevin Tang
Kevin Tang's purchase track record
How the stock did after each of Kevin Tang's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 7/14/2026 | BOLD | $168K | -1.2% | pending | — |
| 7/13/2026 | FULC | $1.49M | +5.9% | pending | — |
| 7/6/2026 | BOLD | $364K | +4.0% | pending | — |
| 6/25/2026 | BOLD | $984K | +3.6% | pending | — |
| 5/29/2026 | AUPH | $12.46M | +6.3% | pending | — |
| 2/27/2026 | AUPH | $12.69M | +8.2% | +15.0% | +12.1% |
| 8/1/2025 | AUPH | $13.59M | +25.6% | +38.5% | +11.2% |
| 2/28/2025 | AUPH | $12.71M | -1.4% | +50.8% | +8.5% |
| 12/5/2024 | AUPH | $10.82M | -7.8% | -8.9% | -2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
AUPH Appears in Report on Activist Investor Activity. Aurinia Pharmaceuticals was mentioned among stocks drawing attention from activist investors, according to recent financial news coverage. No specific activist involvement details or corporate action plans were detailed in the report. The stock is currently trading between its 52-week range extremes, with analysts maintaining price targets notably above current levels.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
APVO to Present Multispecific Platform at SITC 2026 Meeting. Aptevo Therapeutics announced it will showcase its multispecific antibody platform at the upcoming SITC 2026 Annual Meeting. The presentation offers the company a chance to highlight its pipeline to a specialized oncology audience. The stock is currently near a support level and has a relatively low RSI, which may reflect recent price pressure.
Transaction History
| BOLD | ▼ Sell | Open Market | 18,300 | $54K | 8/26/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 2,975 | $7K | 7/21/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 1,623 | $4K | 7/20/2026 | View on chart |
| FULC | ▲ Buy | Open Market | 50,945 | $179K | 7/17/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 265 | $647 | 7/17/2026 | View on chart |
| FULC | ▲ Buy | Open Market | 116,671 | $415K | 7/16/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 18,491 | $45K | 7/16/2026 | View on chart |
| FULC | ▲ Buy | Open Market | 107,377 | $382K | 7/15/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 1,600 | $4K | 7/15/2026 | View on chart |
| FULC | ▲ Buy | Open Market | 53,651 | $191K | 7/14/2026 | View on chart |
| FULC | ▲ Buy | Open Market | 75,952 | $272K | 7/14/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 43,878 | $107K | 7/14/2026 | View on chart |
| FULC | ▲ Buy | Open Market | 12,966 | $46K | 7/13/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 48,211 | $117K | 7/13/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 43,367 | $105K | 7/10/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 7 | $17 | 7/9/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 14,338 | $35K | 7/8/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 15,810 | $39K | 7/7/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 27,062 | $67K | 7/6/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 9,821 | $24K | 7/2/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 71,612 | $178K | 7/1/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 25,930 | $66K | 6/30/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 100 | $250 | 6/30/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 63,985 | $158K | 6/29/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 777 | $2K | 6/29/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 75,047 | $191K | 6/26/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 134 | $340 | 6/26/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 145,880 | $362K | 6/25/2026 | View on chart |
| BOLD | ▲ Buy | Open Market | 510 | $1K | 6/25/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 206,005 | $3.1M | 6/2/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 343,521 | $5.2M | 6/1/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 99 | $2K | 6/1/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 2,299 | $35K | 5/29/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 262,682 | $4.0M | 5/29/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 184,208 | $2.6M | 3/3/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 83,561 | $1.2M | 3/2/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 115,792 | $1.6M | 3/2/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 300,000 | $4.2M | 2/27/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 214,839 | $3.0M | 2/27/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 1,600 | $23K | 2/27/2026 | View on chart |
| AUPH | ▲ Buy | Open Market | 200,000 | $2.3M | 8/5/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 100,000 | $1.1M | 8/4/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 1,000,000 | $10.1M | 8/1/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 148,038 | $1.2M | 3/4/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 500,000 | $4.0M | 3/4/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 100,000 | $809K | 3/4/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 100,720 | $803K | 3/3/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 351,962 | $2.8M | 3/3/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 399,280 | $3.1M | 2/28/2025 | View on chart |
| AUPH | ▲ Buy | Open Market | 500,000 | $4.5M | 12/9/2024 | View on chart |
| AUPH | ▲ Buy | Open Market | 400,000 | $3.6M | 12/6/2024 | View on chart |
| AUPH | ▲ Buy | Open Market | 300,000 | $2.7M | 12/5/2024 | View on chart |
| APVO | ▼ Sell | Open Market | 161,336 | $2.2M | 11/23/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 124,509 | $1.6M | 11/23/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 75,491 | $886K | 11/23/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 149,111 | $1.7M | 11/23/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 50,889 | $531K | 11/23/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 200,000 | $2.0M | 11/23/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 160,000 | $1.5M | 11/23/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 16,667 | $123K | 11/22/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 196,281 | $1.4M | 11/22/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 3,719 | $25K | 11/22/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 38,664 | $253K | 11/22/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 183,333 | $1.4M | 11/19/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 30,467 | $244K | 11/19/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 169,533 | $1.4M | 11/18/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 43,213 | $406K | 11/18/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 152,764 | $1.3M | 11/18/2021 | View on chart |
| APVO | ▼ Sell | Open Market | 4,023 | $32K | 11/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
BOLD trades near support amid sector news
Recent headlines focus on Beam Therapeutics and Callio Therapeutics rather than direct developments for Boundless Bio. The stock is currently trading near its identified support level, with technical indicators showing a breakdown signal. Analysts maintain a single price target of $4.00, which sits above the current trading range.
BOLD trades near support amid sector news. Recent headlines focus on Beam Therapeutics and Callio Therapeutics rather than direct developments for Boundless Bio. The stock is currently trading near its identified support level, with technical indicators showing a breakdown signal. Analysts maintain a single price target of $4.00, which sits above the current trading range.